Medicine cost guides, safety checks and real case studies
30 researched articles on getting discounts, buying safely, verifying generics and understanding why the same molecule costs so differently across borders. Every article starts with an original key-takeaways summary, cites Tier-1 regulators and public health bodies, and carries an explicit record of who wrote and reviewed it.
- 30
- Articles
- 12
- Case studies
- 100%
- Source cited
How to get massive discounts on medicines, injections and treatments
A practical, step-by-step playbook for reducing what you actually pay for prescriptions — without changing the active ingredient or bypassing your doctor.
Read the guide →50–95%
typical reduction when all nine tactics are combined
Where to buy the cheapest safe medications
A comparison of the main legitimate routes to lower-cost medicine, what each one is genuinely good for, and the safety checks that apply to all of them.
Read article →Are Indian generic medicines safe to use?
The honest answer is that safety depends on the manufacturer, not the country — and this article shows you exactly how to tell the difference.
Read article →How to buy discounted medications online safely
Online pharmacies range from fully licensed operations to outright criminal fronts. This is how to tell them apart before you pay.
Read article →Brand vs generic: what 'same salt' actually means
A plain-language explanation of what is identical between a brand and its generic, what is allowed to differ, and why that distinction occasionally matters clinically.
Read article →Is it legal to import medicine for personal use?
A jurisdiction-by-jurisdiction summary of personal importation, written to help you check your own national rule rather than rely on hearsay.
Read article →How to verify that a generic medicine is authentic
Counterfeits are a distribution problem, not a country problem. This is the practical inspection routine that catches most of them.
Read article →Why US drug prices are the highest in the world
An explanation of the market structure behind US pricing, and what that means practically for a patient trying to lower a bill.
Read article →Hepatitis C treatment cost: the widest price gap in medicine
Hepatitis C is the clearest example of a curable disease where price, not science, is the barrier — and of how licensing changed that.
Read article →How to reduce insulin costs safely
Insulin rationing causes hospitalisations and deaths. These are the legitimate ways to lower the bill instead.
Read article →How to reduce cancer medication costs safely
Cancer treatment cost is rarely one number. Breaking it into components shows where savings are genuinely available and where they are not.
Read article →Biosimilars vs generics: what is the actual difference?
Small-molecule generics can be made identical. Biologics cannot — and understanding why explains the whole regulatory difference.
Read article →Patient assistance programmes and how to actually get accepted
Billions in assistance goes unclaimed each year because applications look intimidating. They are usually simpler than they appear.
Read article →How to talk to your doctor about medicine costs
Financial non-adherence is common and dangerous. These scripts make the conversation straightforward for both sides.
Read article →How to spot a fake online pharmacy
Illegitimate pharmacy sites are professionally designed and deliberately convincing. These are the signals that design cannot fake.
Read article →Cold-chain medicine handling: what patients need to check
A temperature excursion can silently destroy a medicine's potency without changing how it looks. These are the checks that protect you.
Read article →Building an annual medicine budget
Most households underestimate annual medicine spending by a wide margin. A simple ledger changes both the number and the decisions.
Read article →What to do when your medicine is out of stock
Shortages are increasingly common. Having a plan turns a crisis into an inconvenience.
Read article →How a $2,000 monthly prescription became $5
One household, four medicines, and the exact line-by-line arithmetic behind a 98% reduction in monthly prescription cost.
$2,046 per month → $28 per month
Read article →A hepatitis C cure that cost $84,000 in one country and $240 in another
The widest documented price gap in modern medicine, explained through one patient's 12-week treatment course.
~$84,000 per course (list) → ~$240 per course (licensed generic reference)
Read article →How a full year of HER2 breast cancer therapy became affordable
A full year of trastuzumab plus supportive care, and how biosimilars changed what that year costs.
~$61,000 for 12 months → ~$11,000 equivalent reference basket
Read article →How one family cut its annual insulin bill by 88%
Two insulin-dependent family members, one budget, and the changes that stopped the rationing.
~$9,400 per year → ~$1,130 per year equivalent basket
Read article →A year of multiple sclerosis therapy: $96,000 versus $1,140
Disease-modifying therapy for MS is lifelong. Over a lifetime, the price difference compounds into an extraordinary figure.
~$96,000 per year → ~$1,140 per year reference
Read article →Adrenaline auto-injectors: why the same drug costs $650 or $45
Adrenaline costs cents. The auto-injector device is what costs hundreds — and that distinction has real safety consequences.
~$650 per two-pack → ~$45 reference equivalent
Read article →HIV antiretroviral therapy: $36,000 a year versus $110
HIV therapy is the clearest proof that licensing and competition can collapse the price of a lifelong medicine without changing the molecule.
~$36,000 per year → ~$110 per year reference
Read article →Rheumatoid arthritis biologic therapy at a fraction of the cost
Biosimilar competition in rheumatology is one of the clearest recent examples of price falling without treatment changing.
~$62,000 per year → ~$5,300 per year reference
Read article →Imatinib for childhood leukaemia at one percent of the price
A targeted therapy that turned a fatal leukaemia into a manageable condition — and the price collapse that followed patent expiry.
~$126,000 per year (branded reference) → ~$1,440 per year reference
Read article →How a retired couple cut $5,000 of annual inhaler costs
Inhaler costs on a fixed income, and why the biggest improvement came from technique rather than price.
~$5,040 per year → ~$810 per year equivalent basket
Read article →Lifetime immunosuppression after a kidney transplant
Transplant medicine is the clearest example of where cheap must never mean casual — and how to switch safely when it is necessary.
~$8,900 per year → ~$1,020 per year reference
Read article →Iron chelation therapy for thalassaemia: a lifetime cost problem solved
Regular transfusions save lives and cause iron overload. The medicine that prevents the resulting organ damage is where the cost sits.
~$50,400 per year → ~$820 per year reference
Read article →